Healthcare
EL.En. S.p.A.(ELEAF)
Live Price
Offline$18.50
+0.00% today
Window Change
+16.10%
Window
May 29, 2026 โ Jun 18, 2026
- Market Cap
- $1.09B
- Revenue Growth
- +4.4%
- EPS Growth
- -15.6%
- Dividend Yield
- 1.6%
Historical coverage is still filling in
This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.
Coverage: 15 bars ยท May 29, 2026 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
EL.En. S.p.A. (ELEAF) is a Healthcare stock with a market cap of $1.09B and listed on OTC. The stock last traded around $18.50 and up 16.1% across the available one-year price window (May 29, 2026 โ Jun 18, 2026). Baseline metrics include revenue growth of +4.4%, EPS growth of -15.6%, a dividend yield of 1.6%. What stands out right now is revenue +4.4%, EPS -15.6%, free cash flow -18.4% with operating margin 11.8% and ROIC 13.4%. The dividend is present but secondary, with a yield around 1.6%. Valuation is more restrained than many high-expectation growth names at P/E 17.1 and price/sales 1.5. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines ELEAF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+4.4% vs +7.6% peer median
Operating Margin
Below sector median
+11.8% vs +19.4% peer median
P/E
Below sector median
17.1 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 15, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +4.4% and EPS is at -15.6%, with operating margin around 11.8%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 1.6%, which matters if the thesis depends on income as much as growth.
Benchmark Edge
ELEAF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
ELEAF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
ELEAF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for ELEAF and SPY.
Company Overview
EL.En. S.p.A.
Other OTC
EL.En. S.p.A. engages in the research and development, manufacture, distribution, and sale of laser systems in Europe and internationally. The company offers medical laser equipment for use in the fields of physiotherapy, orthopedics, traumatology, rheumatology, dermatology, sports and rehabilitative medicines, surgery, aesthetics, and art; and laser sources and systems for cutting, welding, marking, and engraving on countless materials. It also provides laser sources that include liquid, solid, semiconductor, and gas; and after-sales services, such as supplying of spare parts, as well as consulting and technical assistance services. The company was founded in 1981 and is headquartered in Calenzano, Italy.
- Leadership
- Gabriele Clementi
- IPO Date
- Apr 12, 2012
- Employees
- 2.1k
- Street Address
- Via Baldanzese 17
- Mailing
- Calenzano, FI, 50041
- Region
- Calenzano, FI, IT
- Reporting Currency
- USD
- Investor Line
- 39 05 58 82 68 07
- Last Updated
- Apr 28, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 17.1
- EV/EBITDA
- 9.4
- Price/Sales
- 1.5
- Price/Book
- 2.7
Growth
- Revenue
- +4.4%
- EPS
- -15.6%
- Free Cash Flow
- -18.4%
Profitability
- Gross Margin
- 34.3%
- Operating Margin
- 11.8%
- Net Margin
- 8.8%
- ROE
- 16.1%
- ROIC
- 13.4%
Balance Sheet
- Debt/Equity
- 0.09
- Current Ratio
- 3.10
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.